Sun Yat-sen University

This study tests a combination of three drugs (surufatinib, sintilimab, and AG) as a first treatment for people with advanced pancreatic cancer that cannot be removed by surgery. The goal is to see if this mix can shrink tumors or slow the disease. About 32 adults who have not ha…

This study tests whether combining targeted radiation (SBRT), an immunotherapy drug (PD-1 antibody), and chemotherapy can help control nasopharyngeal cancer that has spread to up to five spots in the body. About 41 adults who have not had prior treatment for their advanced cancer…

This study looks at men whose prostate cancer has spread to nearby lymph nodes after surgery. It compares standard hormone therapy alone versus hormone therapy plus pelvic radiation. The goal is to see if the combination delays cancer return and improves survival. About 374 parti…

This study tests whether adding the drug apatinib to standard chemotherapy and radiation helps people with advanced esophageal cancer that cannot be removed by surgery. About 170 adults with this type of cancer will be randomly assigned to receive the standard treatment with or w…

This study tests a combination of two drugs (toripalimab and bevacizumab) alongside three different artery-directed treatments for people with liver cancer that cannot be removed by surgery. The goal is to see which artery treatment works best with the drug combo to control the c…

This study tests a new drug called cadonilimab, given with chemotherapy and radiation, for people with advanced esophageal cancer that cannot be removed by surgery. The goal is to see if this combination can help control the cancer longer and reduce the chance of it coming back. …

This study tests whether using smaller radiation targets after chemotherapy can control advanced nasopharyngeal cancer while reducing side effects. About 445 patients with stage III to IVa disease will receive standard chemotherapy followed by either standard or reduced radiation…

This study tests whether adding anlotinib hydrochloride to the standard Stupp regimen can help people with newly diagnosed glioblastoma, an aggressive brain cancer. About 150 adults aged 18-75 will receive either the combination or standard treatment alone. The main goal is to se…

This study tests a combination of three drugs (anlotinib, penpulimab, and capecitabine) as a first treatment for people whose nasopharyngeal cancer has spread or returned. About 59 adults aged 18–65 with measurable tumors will receive the therapy. The main goal is to see how long…

This study tests a treatment plan for muscle-invasive bladder cancer that avoids removing the bladder. Patients first receive chemotherapy plus an immunotherapy drug (toripalimab), followed by radiation therapy with more immunotherapy. The goal is to see if this combination can d…

This study looks at whether giving a single spinal injection of morphine before laparoscopic colon cancer surgery can improve how well patients recover. Many patients still have moderate to severe pain after this surgery, which can slow recovery and increase the need for other pa…

This study looks at how the bacteria in the gut (microbiome) are linked to cancer-related symptoms in children aged 5-18 with acute lymphoblastic leukemia. Researchers will collect stool samples and symptom reports at several points during chemotherapy. The goal is to understand …